Guo X, Kong L, Wen Y, Chen L, Hu S
BMC Psychiatry. 2024; 24(1):695.
PMID: 39415112
PMC: 11481721.
DOI: 10.1186/s12888-024-06141-z.
Ab Rajab N, Yasin M, Ghazali W, Talib N, Taib W, Sulong S
Yale J Biol Med. 2024; 97(3):281-295.
PMID: 39351328
PMC: 11426293.
DOI: 10.59249/FBOT5313.
Liu Y, Liao Y, Lin K
Neuropsychiatr. 2024; 38(4):163-173.
PMID: 38833151
DOI: 10.1007/s40211-024-00499-y.
Eaton W, Rodriguez K, Thomas M, Johnson J, Talor M, Dohan C
Psychiatry Res. 2022; 317:114812.
PMID: 36058039
PMC: 10984252.
DOI: 10.1016/j.psychres.2022.114812.
Romao V, Fonseca J
Front Med (Lausanne). 2021; 8:689698.
PMID: 34901047
PMC: 8661097.
DOI: 10.3389/fmed.2021.689698.
Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data.
Malavia T, Chaparala S, Wood J, Chowdari K, Prasad K, McClain L
NPJ Schizophr. 2017; 3:11.
PMID: 28560257
PMC: 5441529.
DOI: 10.1038/s41537-017-0010-z.
Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders.
Morgan L, Rollins B, Sequeira A, Byerley W, DeLisi L, Schatzberg A
Microarrays (Basel). 2016; 5(1).
PMID: 26998349
PMC: 4795482.
DOI: 10.3390/microarrays5010006.
Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.
Severance E, Yolken R, Eaton W
Schizophr Res. 2014; 176(1):23-35.
PMID: 25034760
PMC: 4294997.
DOI: 10.1016/j.schres.2014.06.027.
The epidemiologic evidence linking autoimmune diseases and psychosis.
Benros M, Eaton W, Mortensen P
Biol Psychiatry. 2013; 75(4):300-6.
PMID: 24199668
PMC: 8797267.
DOI: 10.1016/j.biopsych.2013.09.023.
NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology.
Schiavone S, Jaquet V, Sorce S, Dubois-Dauphin M, Hultqvist M, Backdahl L
Transl Psychiatry. 2012; 2:e111.
PMID: 22832955
PMC: 3365255.
DOI: 10.1038/tp.2012.36.
Paradox of schizophrenia genetics: is a paradigm shift occurring?.
Doi N, Hoshi Y, Itokawa M, Yoshikawa T, Ichikawa T, Arai M
Behav Brain Funct. 2012; 8:28.
PMID: 22650965
PMC: 3487746.
DOI: 10.1186/1744-9081-8-28.
Cognition, dopamine and bioactive lipids in schizophrenia.
Condray R, Yao J
Front Biosci (Schol Ed). 2011; 3(1):298-330.
PMID: 21196378
PMC: 3060944.
DOI: 10.2741/s153.
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
Yao J, Keshavan M
Antioxid Redox Signal. 2010; 15(7):2011-35.
PMID: 21126177
PMC: 3159108.
DOI: 10.1089/ars.2010.3603.
Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.
Muller N, Schwarz M
Neurotox Res. 2006; 10(2):131-48.
PMID: 17062375
DOI: 10.1007/BF03033242.
Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.
Sperner-Unterweger B
Drugs. 2005; 65(11):1493-520.
PMID: 16033289
DOI: 10.2165/00003495-200565110-00004.
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.
Hanson D, Gottesman I
BMC Med Genet. 2005; 6:7.
PMID: 15707482
PMC: 554096.
DOI: 10.1186/1471-2350-6-7.